Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 AUD | 0.00% | +11.11% | +37.93% |
Feb. 23 | Apiam Animal Health Limited acquired Macleay Valley Veterinary Services Pty Ltd for AUD 3.6 million. | CI |
Feb. 22 | Transcript : Apiam Animal Health Limited, H1 2024 Earnings Call, Feb 23, 2024 |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 78.52 | 55.07 | 53.63 | 126.8 | 115.7 | 91.8 |
Enterprise Value (EV) 1 | 104.4 | 79.94 | 102.2 | 179.7 | 176.3 | 186.7 |
P/E ratio | 23.4 x | 17.3 x | 12.6 x | 23.1 x | 20.4 x | 39.8 x |
Yield | 2.13% | 3.08% | 4.35% | 2.5% | 2.34% | - |
Capitalization / Revenue | 0.74 x | 0.49 x | 0.45 x | 1 x | 0.74 x | 0.48 x |
EV / Revenue | 0.98 x | 0.72 x | 0.86 x | 1.42 x | 1.12 x | 0.97 x |
EV / EBITDA | 12.1 x | 8.67 x | 9.24 x | 15.4 x | 12.6 x | 15.2 x |
EV / FCF | 24 x | 34.1 x | 12.6 x | 40.8 x | 15.4 x | 21.1 x |
FCF Yield | 4.16% | 2.93% | 7.93% | 2.45% | 6.51% | 4.74% |
Price to Book | 1.35 x | 0.91 x | 0.79 x | 1.61 x | 1.1 x | 0.78 x |
Nbr of stocks (in thousands) | 104,694 | 105,898 | 116,597 | 132,055 | 168,928 | 180,005 |
Reference price 2 | 0.7500 | 0.5200 | 0.4600 | 0.9600 | 0.6850 | 0.5100 |
Announcement Date | 8/26/18 | 8/25/19 | 8/23/20 | 8/29/21 | 8/28/22 | 8/27/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 106.6 | 111.7 | 118.3 | 126.2 | 157.1 | 191.8 |
EBITDA 1 | 8.647 | 9.222 | 11.07 | 11.7 | 14.04 | 12.26 |
EBIT 1 | 6.215 | 6.064 | 7.766 | 8.277 | 9.584 | 6.569 |
Operating Margin | 5.83% | 5.43% | 6.56% | 6.56% | 6.1% | 3.43% |
Earnings before Tax (EBT) 1 | 4.831 | 4.569 | 6.065 | 7.036 | 6.47 | 3.166 |
Net income 1 | 3.278 | 3.165 | 4.171 | 5.082 | 4.639 | 2.277 |
Net margin | 3.08% | 2.83% | 3.52% | 4.03% | 2.95% | 1.19% |
EPS 2 | 0.0321 | 0.0301 | 0.0365 | 0.0416 | 0.0336 | 0.0128 |
Free Cash Flow 1 | 4.346 | 2.342 | 8.11 | 4.401 | 11.48 | 8.848 |
FCF margin | 4.08% | 2.1% | 6.85% | 3.49% | 7.31% | 4.61% |
FCF Conversion (EBITDA) | 50.26% | 25.39% | 73.27% | 37.63% | 81.77% | 72.19% |
FCF Conversion (Net income) | 132.57% | 73.98% | 194.43% | 86.6% | 247.42% | 388.58% |
Dividend per Share 2 | 0.0160 | 0.0160 | 0.0200 | 0.0240 | 0.0160 | - |
Announcement Date | 8/26/18 | 8/25/19 | 8/23/20 | 8/29/21 | 8/28/22 | 8/27/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2021 S1 | 2021 S2 | 2022 S1 |
---|---|---|---|
Net sales | - | 65 | - |
EBITDA | - | 7.7 | - |
EBIT | 4.4 | 4.4 | - |
Operating Margin | - | 6.77% | - |
Earnings before Tax (EBT) | - | - | - |
Net income 1 | 2.559 | 2.5 | 1.75 |
Net margin | - | 3.85% | - |
EPS 2 | - | 0.0216 | 0.000100 |
Dividend per Share | - | - | - |
Announcement Date | 2/23/21 | 8/29/21 | 2/24/22 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 25.8 | 24.9 | 48.6 | 52.9 | 60.5 | 94.9 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.987 x | 2.697 x | 4.39 x | 4.523 x | 4.314 x | 7.739 x |
Free Cash Flow 1 | 4.35 | 2.34 | 8.11 | 4.4 | 11.5 | 8.85 |
ROE (net income / shareholders' equity) | 5.81% | 5.25% | 6.61% | 6.69% | 4.79% | 1.92% |
ROA (Net income/ Total Assets) | 3.87% | 3.61% | 3.95% | 3.47% | 3.36% | 1.84% |
Assets 1 | 84.64 | 87.62 | 105.5 | 146.5 | 138 | 123.5 |
Book Value Per Share 2 | 0.5500 | 0.5700 | 0.5800 | 0.6000 | 0.6200 | 0.6500 |
Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0200 | 0.0200 | 0.0200 | 0.0200 |
Capex 1 | 4.55 | 2.13 | 1.65 | 4.74 | 4.32 | 7.86 |
Capex / Sales | 4.26% | 1.9% | 1.39% | 3.75% | 2.75% | 4.1% |
Announcement Date | 8/26/18 | 8/25/19 | 8/23/20 | 8/29/21 | 8/28/22 | 8/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.93% | 47.33M | |
-33.57% | 130M |
- Stock Market
- Equities
- AHX Stock
- Financials Apiam Animal Health Limited